文献速递颈动脉与弓上血管

既往同侧颈动脉支架置入患者颈动脉血运重建的结局:血管质量倡议分析

Outcomes following carotid revascularization in patients with prior ipsilateral carotid artery stenting in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2024-08-22

基于血管质量倡议2016至2023年数据,比较既往同侧颈动脉支架置入后接受经颈动脉血运重建(TCAR)、经股动脉颈动脉支架置入(tfCAS)或颈动脉内膜剥脱术(CEA)的2137例患者围术期结局。无症状患者中TCAR较tfCAS的院内卒中/死亡未达统计学显著降低,较CEA卒中/死亡相当但术后心肌梗死和颅神经损伤更低;症状性患者TCAR院内卒中/死亡高达5.1%。TCAR比例从2016年14%增至2023年41%。

要点

  • 无症状既往同侧CAS患者中,TCAR较tfCAS的院内卒中/死亡未达统计学显著差异(0.7%对2.0%,aOR 0.33,95%CI 0.11-1.05,P=.06)。
  • 无症状患者中TCAR较CEA卒中/死亡相当(0.7%对0.9%),但术后心肌梗死(0.1%对14%)、卒中/死亡/心肌梗死(0.8%对15%)和颅神经损伤(0.1%对3.8%)更低。
  • 症状性患者中TCAR院内卒中/死亡为5.1%,颅神经损伤低于CEA。

核心结论

  • 无症状既往同侧CAS患者中,TCAR较tfCAS的院内卒中/死亡未达统计学显著降低,较CEA卒中/死亡相当但术后心肌梗死和颅神经损伤更低。
  • 症状性患者中TCAR的院内卒中/死亡不可接受地升高。
  • 与术后结局一致,既往同侧支架置入患者中选择TCAR的比例随时间稳步增加。

研究设计与样本

  • 基于血管质量倡议(Vascular Quality Initiative)2016至2023年数据的比较研究。
  • 纳入既往同侧颈动脉支架置入后接受TCAR、tfCAS或CEA的患者共2137例:TCAR 668例(31%)、tfCAS 1128例(53%)、CEA 341例(16%)。
  • 采用倾向评分逆概率加权和加权logistic回归比较院内卒中、院内死亡、卒中/死亡、术后心肌梗死、卒中/死亡/心肌梗死、30天死亡率和颅神经损伤。
  • 使用Cochrane-Armitage趋势检验分析三种血运重建方式比例随时间的变化趋势。

主要发现

  • 无症状患者中TCAR较tfCAS的院内卒中/死亡为0.7%对2.0%(aOR 0.33,95%CI 0.11-1.05,P=.06),未达统计学显著。
  • 无症状患者中TCAR较CEA的院内卒中/死亡为0.7%对0.9%(aOR 0.80,95%CI 0.16-3.98,P=.8)。
  • 无症状患者中TCAR较CEA的术后心肌梗死为0.1%对14%(aOR 0.02,95%CI 0.00-0.10,P<.001),卒中/死亡/心肌梗死为0.8%对15%(aOR 0.05,95%CI 0.01-0.25,P<.001),颅神经损伤为0.1%对3.8%(aOR 0.04,95%CI 0.00-0.30,P=.002)。
  • 症状性患者中TCAR的院内卒中/死亡为5.1%,颅神经损伤低于CEA。
  • TCAR比例从2016年14%增至2023年41%,tfCAS从61%降至45%,CEA从25%降至14%(P<.001)。

临床怎么用

  • 原文结论指出,在无症状既往同侧CAS患者中,TCAR较tfCAS与更低的院内卒中/死亡几率相关,较CEA卒中/死亡相当但术后心肌梗死和颅神经损伤更低。
  • 原文结论指出,在症状性患者中,TCAR与不可接受地升高的院内卒中/死亡率相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The outcomes of carotid revascularization in patients with prior carotid artery stenting (CAS) remain understudied. Prior research has not reported the outcomes after transcarotid artery revascularization (TCAR) in patients with previous CAS. In this study, we compared the peri-operative outcomes of TCAR, transfemoral CAS (tfCAS) and carotid endarterectomy (CEA) in patients with prior ipsilateral CAS using the Vascular Quality Iniatitive. METHODS: Using Vascular Quality Initiative data from 2016 to 2023, we identified patients who underwent TCAR, tfCAS, or CEA after prior ipsilateral CAS. We included covariates such as age, race, sex, body mass index, comorbidities (hypertension, diabetes, prior coronary artery disease, prior coronary artery bypass grafting/percutaneous coronary intervention, congestive heart failure, renal dysfunction, smoking, chronic obstructive pulmonary disease, and anemia), symptom status, urgency, ipsilateral stenosis, and contralateral occlusion into a regression model to compute propensity scores for treatment assignment. We then used the propensity scores for inverse probability weighting and weighted logistic regression to compare in-hospital stroke, in-hospital death, stroke/death, postoperative myocardial infarction (MI), stroke/death/MI, 30-day mortality, and cranial nerve injury (CNI) after TCAR, tfCAS, and CEA. We also analyzed trends in the proportions of patients undergoing the three revascularization procedures over time using Cochrane-Armitage trend testing. RESULTS: We identified 2137 patients undergoing revascularization after prior ipsilateral carotid stenting: 668 TCAR patients (31%), 1128 tfCAS patients (53%), and 341 CEA patients (16%). In asymptomatic patients, TCAR was associated with a lower yet not statistically significant in-hospital stroke/death than tfCAS (TCAR vs tfCAS: 0.7% vs 2.0%; adjusted odds ratio [aOR], 0.33; 95% confidence interval [CI], 0.11-1.05; P = .06), and similar odds of stroke/death with CEA (TCAR vs CEA: 0.7% vs 0.9%; aOR, 0.80; 95% CI, 0.16-3.98; P = .8). Compared with CEA, TCAR was associated with lower odds of postoperative MI (0.1% vs 14%; aOR, 0.02; 95% CI, 0.00-0.10; P < .001), stroke/death/MI (0.8% vs 15%; aOR, 0.05; 95% CI, 0.01-0.25; P < .001), and CNI (0.1% vs 3.8%; aOR, 0.04; 95% CI, 0.00-0.30; P = .002) in this patient population. In symptomatic patients, TCAR had an unacceptably elevated in-hospital stroke/death rate of 5.1%, with lower rates of CNI than CEA. We also found an increasing trend in the proportion of patients undergoing TCAR following prior ipsilateral carotid stenting (2016 to 2023: 14% to 41%), with a relative decrease in proportions of tfCAS (61% to 45%) and CEA (25% to 14%) (P < .001). CONCLUSIONS: In asymptomatic patients with prior ipsilateral CAS, TCAR was associated with lower odds of in-hospital stroke/death compared with tfCAS, with comparable stroke/death but lower postoperative MI and CNI rates compared with CEA. In symptomatic patients, TCAR was associated with unacceptably higher in-hospital stroke/death rates. In line with the postprocedure outcomes, there has been a steady increase in the proportion of patients with prior ipsilateral stenting undergoing TCAR over time.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jabbour G, Yadavalli SD, Rastogi V, et al. Outcomes following carotid revascularization in patients with prior ipsilateral carotid artery stenting in the Vascular Quality Initiative. J Vasc Surg. 2024. PMID: 39179002. doi:10.1016/j.jvs.2024.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。